Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +26.45% | +35.67% | +89.94% | +89.58% | +77.04% |
| Weighted Average Shares Diluted Growth | +26.45% | +35.67% | +89.94% | +89.58% | +77.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -29.66% | -22.15% | -25.15% | -25.32% | +22.50% |
| Book Value per Share Growth | -47.33% | -44.36% | -60.78% | -61.18% | -25.02% |
| Debt Growth | +9.53% | +13.59% | -21.60% | -20.71% | -20.41% |
| R&D Expense Growth | -18.27% | -15.88% | -23.31% | -24.51% | -20.82% |
| SG&A Expenses Growth | +6.61% | -1.37% | +10.92% | -41.69% | +31.47% |